The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review*
Authors:
- Juliet C. HockenhullJHJuliet C. Hockenhull
- Kerry M. DwanKDKerry M. Dwan
- Godfrey W. SmithGSGodfrey W. Smith
- Carrol L. GambleCGCarrol L. Gamble
- Angela BolandABAngela Boland
- Tom J. WalleyTWTom J. Walley
- Rumona C. DicksonRDRumona C. Dickson
- 1 February 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 37 (2) , 702-712
Abstract
To assess the clinical effectiveness of central venous catheters (CVCs) treated with anti-infective agents (AI-CVCs) in preventing catheter-related bloodstream infections (CRBSI). MEDLINE (OVID), EMBASE, SCI//Web of Science, SCI/ISI Proceedings, and the Cochrane Library. A systematic review of the literature was conducted using internationally recognized methodology. All included articles were reports of randomized controlled trials comparing the clinical effectiveness of CVCs treated with AI-CVCs with either standard CVCs or another anti-infective treated catheter. Articles requiring in-house preparation of catheters or that only reported interim data were excluded. Data extraction was carried out independently and crosschecked by two reviewers using a pretested data extraction form. Meta-analyses were conducted to assess the effectiveness of AI-CVCs in preventing CRBSI, compared with standard CVCs. Results are presented in forest plots with 95% confidence intervals. Thirty-eight randomized controlled trials met the inclusion criteria. Methodologic quality was generally poor. Meta-analyses of data from 27 trials assessing CRBSI showed a strong treatment effect in favor of AI-CVCs (odds ratio 0.49 (95% confidence interval 0.37-0.64) fixed effects, test for heterogeneity, chi-square = 28.78, df = 26, p = 0.321, I = 9.7). Results subgrouped by the different types of anti-infective treatments generally demonstrated treatment effects favoring the treated catheters. Sensitivity analyses investigating the effects of methodologic differences showed no differences to the overall conclusions of the primary analysis. AI-CVCs appear to be effective in reducing CRBSI compared with standard CVCs. However, it is important to establish whether this effect remains in settings where infection-prevention bundles of care are established as routine practice. This review does not address this question and further research is required.Keywords
This publication has 53 references indexed in Scilit:
- epic2: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in EnglandJournal of Hospital Infection, 2007
- Antimicrobially Impregnated Catheters: An Overview of Randomized Controlled TrialsThe Journal of Vascular Access, 2003
- Prevention of Bloodstream Infections With Central Venous Catheters Treated With Anti-Infective Agents Depends on Catheter Type and Insertion Time: Evidence From a Meta-AnalysisInfection Control & Hospital Epidemiology, 2002
- Central venous catheter useIntensive Care Medicine, 2001
- Antimicrobial-Coated/Bonded and -Impregnated Intravascular CathetersAnnals of Pharmacotherapy, 2001
- The epic Project: Developing National Evidence-based Guidelines for Preventing Healthcare associated InfectionsJournal of Hospital Infection, 2001
- Prevention of nosocomial bloodstream infections: Effectiveness of antimicrobial-impregnated and heparin-bonded central venous cathetersCritical Care Medicine, 2000
- Efficacy of Antiseptic-Impregnated Central Venous Catheters in Preventing Catheter-Related Bloodstream InfectionJAMA, 1999
- Meta-analysis: Principles and proceduresBMJ, 1997
- Guidelines for good practice in central venous catheterizationJournal of Hospital Infection, 1994